A. Tournoux

562 total citations
11 papers, 414 citations indexed

About

A. Tournoux is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, A. Tournoux has authored 11 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Psychiatry and Mental health and 4 papers in Experimental and Cognitive Psychology. Recurrent topics in A. Tournoux's work include Treatment of Major Depression (8 papers), Electroconvulsive Therapy Studies (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). A. Tournoux is often cited by papers focused on Treatment of Major Depression (8 papers), Electroconvulsive Therapy Studies (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). A. Tournoux collaborates with scholars based in France, Austria and Germany. A. Tournoux's co-authors include Yannick Plétan, J.D. Guelfi, J. J. López-Ibor, J. F. Prost, Siegfried Kasper, Nicole Pezous, Y. Lecrubier, Emmanuelle Corruble, D. Sechter and Jean‐Claude Samuelian and has published in prestigious journals such as Journal of Affective Disorders, Acta Psychiatrica Scandinavica and Journal of Psychopharmacology.

In The Last Decade

A. Tournoux

11 papers receiving 392 citations

Peers

A. Tournoux

PHARM

PMH

CMN

ECP

MB

André Nayer Belgium

M. Zivkov United States

L. Timmerman Netherlands

J O Cole United States

Stephen T.H. Sokolov Canada

John Scott Carman United States

Birgitte Søgaard Denmark

S Brion United States

Sara Gibiino Italy

M Ferreri France

André Nayer Belgium

A. Tournoux

206 ×0.8

PHARM

251 ×1.3

PMH

73 ×0.8

CMN

87 ×1.1

ECP

40 ×0.7

MB

Citations per year, relative to A. Tournoux A. Tournoux (= 1×) peers André Nayer

Countries citing papers authored by A. Tournoux

Since Specialization

Citations

This map shows the geographic impact of A. Tournoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tournoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tournoux more than expected).

Fields of papers citing papers by A. Tournoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Tournoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tournoux. The network helps show where A. Tournoux may publish in the future.

Co-authorship network of co-authors of A. Tournoux

This figure shows the co-authorship network connecting the top 25 collaborators of A. Tournoux. A scholar is included among the top collaborators of A. Tournoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tournoux. A. Tournoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Wilson, Sue, Jayne Bailey, Ann Rich, et al.. (2005). The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. Journal of Psychopharmacology. 19(6). 609–613. 25 indexed citations

2.

Sechter, D., et al.. (2004). A comparative study of milnacipran and paroxetine in outpatients with major depression. Journal of Affective Disorders. 83(2-3). 233–236. 38 indexed citations

3.

Poirier, Marie, A. Galinowski, I. Amado, et al.. (2004). Double‐blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteers. Human Psychopharmacology Clinical and Experimental. 19(1). 1–7. 13 indexed citations

4.

Tournoux, A., et al.. (2002). A randomised, double-blind comparison of milnacipran and imipramine in the treatment of depression. Journal of Affective Disorders. 72(1). 21–31. 25 indexed citations

5.

Guelfi, J.D., M. Ansseau, Emmanuelle Corruble, et al.. (1998). A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. International Clinical Psychopharmacology. 13(3). 121–128. 43 indexed citations

6.

Tignol, Jean-Pierre, et al.. (1998). Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode. Acta Psychiatrica Scandinavica. 97(2). 157–165. 37 indexed citations

7.

Lecrubier, Y., et al.. (1996). Clinical efficacy of milnacipran. International Clinical Psychopharmacology. 11. 29–34. 44 indexed citations

8.

Kasper, Siegfried, et al.. (1996). Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression. International Clinical Psychopharmacology. 11. 35–40. 70 indexed citations

9.

López-Ibor, J. J., J.D. Guelfi, Yannick Plétan, A. Tournoux, & J. F. Prost. (1996). Milnacipran and selective serotonin reuptake inhibitors in major depression. International Clinical Psychopharmacology. 11. 41–46. 94 indexed citations

10.

Denis, Josiane, et al.. (1983). [Double-blind treatment of ocular herpes simplex: Vira-A and acyclovir].. PubMed. 83(1). 25–9. 5 indexed citations

11.

Colin, J., A. Tournoux, C Chastel, & G Renard. (1981). [Superficial herpes simplex keratitis. Double-blind comparative trial of acyclovir and idoxuridine (author's transl)].. PubMed. 10(36). 2969–70, 2975. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact